Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Latest "autologous Epstein Barr virus transformed lymphoblastoid cell vaccine" News Stories

05:52 EDT 23rd July 2014 | BioPortfolio

Here are the most relevant search results for "autologous Epstein Barr virus transformed lymphoblastoid cell vaccine" found in our extensive news archives from over 250 global news sources.

More Information about autologous Epstein Barr virus transformed lymphoblastoid cell vaccine on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about autologous Epstein Barr virus transformed lymphoblastoid cell vaccine for you to read. Along with our medical data and news we also list autologous Epstein Barr virus transformed lymphoblastoid cell vaccine Clinical Trials, which are updated daily. BioPortfolio also has a large database of autologous Epstein Barr virus transformed lymphoblastoid cell vaccine Companies for you to search.

Showing "autologous Epstein Barr virus transformed lymphoblastoid cell vaccine" News Articles 1–25 of 13,000+

Extremely Relevant

Epstein-Barr Virus (EBV) Could Prevent 200,000 Cancer Cases A Year

Monday marked the 50 years since Dr Anthony Epstein and Dr Yvonne Barr discovered the Epstein-Barr Virus. The virus, also called EBV, is thought to have infected up to 95% of the World’s population, and has links to the formation of a number of cancers and diseases. The vast majority of people contract EBV as a […]

Developing a vaccine for the Epstein-Barr Virus could prevent up to 200,000 cancers globally, say experts

A vaccine to prevent infection with a common herpes virus, the Epstein-Barr Virus (EBV), could help prevent up to 200,000 new cancers worldwide per year, say Cancer Research UK experts to mark the 50th anniversary of EBV’s discovery. Around 95 per...

Cancer Research UK launches Epstein Barr Virus vaccine trial

The trial is being presented at a conference to mark 50 years since Cancer Research UK first discovered the link between the EBV virus and cancer. The Epstein-Barr virus (EBV) infects most people in the UK, although it rarely causes medical problems...

Epstein-Barr virus and the immune system – are cures in sight?

Concluding our story on Epstein-Barr virus and cancer, we explore the ongoing research into the virus and how this could lead to treatments in the future.

Cancer Research UK launches trial to fight cancer caused by a common virus

Cancer Research UK's Drug Development Office (DDO) has launched a trial of a vaccine to treat some forms of cancer caused by a common virus known as the Epstein Barr Virus (EBV).The trial is being presented today (Tuesday 25 March) at a conference to...

50 years of Epstein-Barr virus

50 years ago three scientists published their findings on the first human virus that can cause cancer - read about the story of Epstein-Barr virus.

Researchers Discover How the Epstein Barr Virus Hijacks Human Cells

University of Montreal researchers have discovered how a component of the Epstein Barr (EBV) virus takes over our cells gene regulating machinery, allowing the virus to replicate itself. The EBV virus causes a variety of diseases such as Hodgkin’s lymphoma and Burkitt’s lymphoma, with the most prevalent disease being infectious

Epstein Barr: How the 'kissing disease' virus hijacks human cells

A component of the Epstein Barr (EBV) virus takes over our cells gene regulating machinery, allowing the virus to replicate itself, researchers have discovered. The EBV virus causes a variety of diseases such as Hodgkin’s lymphoma and Burkitt’s l...

High dose vitamin C therapy may have positive effect on Epstein-Barr virus infection

The Epstein-Barr virus (EBV) is a member of the herpes family that targets lymphocytes and epithelial cells. While the infection is usually benign, it can in some cases lead to acute infectious mononucleosis and can impair the immune system. EBV is a...

Computer-designed protein triggers self-destruction of Epstein-Barr-infected cancer cells

A protein molecule, "BINDI," has been built to trigger self-destruction of cancer cells infected with the Epstein-Barr virus.

Epstein-Barr Negative Lymphoma-Derived Cell Lines

The National Institutes of Health developed multiple lymphoid cell lines that were derived from patients with undifferentiated lymphoma of Burkitt's or non-Burkitt's type (now known as Burkitt and Burkitt-like lymphoma). Burkitt lymphoma is a highly aggressive B-cell lymphoma, which accounts for approximately half of all non Hodgkin’s lymphomas in children. It also occurs in adults, a...

University of Montreal scientists discover molecular details of kissing disease virus attacks

University of Montreal researchers have discovered how a component of the Epstein Barr (EBV) virus takes over our cells gene regulating machinery, allowing the virus to replicate itself.

Medical News Today: How does the 'kissing disease' replicate itself?

Researchers have discovered how Epstein-Barr virus takes over cells, allowing the virus to make a copy of itself - a finding that could produce drug targets.

G-quadruplexes regulate Epstein-Barr virus–encoded nuclear antigen 1 mRNA translation

The impact of plasma epstein–barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study

Epstein-Barr Viral Infections - Pipeline Review, H1 2014

Recently added to the BioPortfolio report store, Epstein-Barr Viral Infections - Pipeline Review, H1 2014 is a new report from Global Markets Direct published on 2014-05-20. This 53-page report is available in PDF from $2000. Epstein-Barr Viral Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Epstein-Barr Viral Infections - Pipeline Review, H1 2014’, provides an over...

Connective tissue diseases: Epstein–Barr virus in Sjögren's syndrome salivary glands drives local autoimmunity

How BINDI – a computer-designed protein – causes cancer cell death

Image: UW Institute for Protein Design A fascinating paper from the UW Institute for Protein Design was released in the scientific journal Cell last week. It described the design and development of a completely new protein which binds and inhibits cancer-causing protein BHRF1. BHRF1 is encoded by the Epstein-Barr virus (EBV) and is responsible for […]

In vivo intratumoral Epstein–Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications

Researchers discover how the kissing disease virus hijacks human cells

(University of Montreal) University of Montreal researchers have discovered how a component of the Epstein Barr (EBV) virus takes over our cells gene regulating machinery, allowing the virus to replicate itself. The EBV virus causes a variety of dise...

News digest – £8m from #nomakeupselfie, 50 years of Epstein-Barr virus, lung cancer discovery and more

From the unprecedented £8m raised by #nomakeupselfie to the 50th anniversary of a cancer causing virus, our weekly news digest keeps you up to date.

How the kissing disease virus hijacks human cells

A component of the Epstein Barr (EBV) virus takes over our cells gene regulating machinery, allowing the virus to replicate itself, researchers have discovered. The EBV virus causes a variety of diseases such as Hodgkin’s lymphoma and Burkitt’s l...

Researchers discover how of EBV virus takes over human cells gene regulating machinery

University of Montreal researchers have discovered how a component of the Epstein Barr (EBV) virus takes over our cells gene regulating machinery, allowing the virus to replicate itself.

Researchers discover how the kissing disease virus hijacks human cells

University of Montreal researchers have discovered how a component of the Epstein Barr (EBV) virus takes over our cells gene regulating machinery, allowing the virus to replicate itself. The EBV virus causes a variety of diseases such as Hodgkin's ly...

TGI Friday! Our weekly round-up of recently published research abstracts | 28 February 2014

From the Indian Journal of Haematology and Blood Transfusion, March 2014 Epublished 25 October 2012. Epstein-Barr Virus Infection Masquerading as Acute Leukemia: A Report of Two Cases and Review of...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement